Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19
试验速览
- 阶段
- 不适用
- 入组人数
- 218
- 试验地点
- 1
- 主要终点
- olfaction
研究概览
简要总结
Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients with COVID-19
详细描述
AIM OF THE STUDY AND WORK PLAN COVID-19 Hospitalized patients with confirmed diagnosis of disease will
- undergo questionnaire for prevalence of Anosmia/dysgeusia
- linking the anosmia/dysgeusia to the degree of disease and treatment outcomes.
- looking to improvement in anosmia/dysgeusia and its timing,
METHODOLOGY Ethical committee approval for the current study protocol will be obtained. Patients will be invited to participate and the informed consent will be signed.
Subjects and Setting:
The clinical data of 218 patients with laboratory-confirmed COVID-19 infection will be collected from Ain Shams University Hospitals. In addition, other patients, infected physicians and nurses may voluntarily enroll in the study. Comorbidities as diabetes mellitus or hypertension, and chronic treatment lines taken will be documented, and considered in the analysis of the data. Patients would be receiving the ASU treatment protocol for covid 19.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adult (>18 year); laboratory-confirmed COVID-19 infection (reverse transcription polymerase chain reaction, RT-PCR).
排除标准
- •patients with olfactory or gustatory dysfunctions before the epidemic; patients without a laboratory-confirmed COVID-19 infection diagnosis; patients who were in the intensive care unit at the time of the study (due to their health status).
结局指标
主要结局
olfaction
时间窗: one month
subjective on a scale from 1 to 5 ( 1 is the least and 5 is the best ) , the score will be recorded for olfaction before and after the olfactory loss
次要结局
- gustation(one month)
研究者
Mohamed Shehata Taha
Professor Doctor
Ain Shams University